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Abstract
Background: Medicare beneficiaries without prescription drug coverage consistently fill fewer
prescriptions than beneficiaries with some form of drug coverage due to cost. ESRD patients, who
are disproportionately poor and typically use multiple oral medications, would likely benefit
substantially from any form of prescription drug coverage. Because most hemodialysis patients are
Medicare-eligible, they as well as their providers would be expected to be well informed of changes
in Medicare prescription drug coverage. By examining the level of understanding and use of the
temporary Medicare Prescription Drug Discount Card Program in the hemodialysis population, we
can gain a better understanding of the potential long-term utilization for Medicare Part D.
Methods: We surveyed English-speaking adult hemodialysis patients with Medicare coverage from
two urban hemodialysis centers affiliated with the University of California San Francisco (UCSF)
during July and August 2005 (n = 70). We also surveyed University- and community-based
nephrologists and non-physician dialysis health care professionals over the same time frame (n =
70).
Results: Fifty-nine percent of patients received prescription drug coverage through Medi-Cal, 20%
through another insurance program, and 21% had no prescription drug coverage. Forty percent of
patients with no prescription drug coverage reported "sometimes" or "rarely" being able to obtain
medications vs. 22% of patients with some form of drug coverage. None of the patients surveyed
actually had a Medicare-approved prescription drug card, and of those who intended to apply, only
10% reported knowing how to do so. Only 11% health care professionals knew the eligibility
requirements of the drug discount cards.
Conclusion: Despite a significant need, hemodialysis patients and providers were poorly educated
about the Medicare Prescription Drug Discount Cards. This has broad implications for the
dissemination of information about Medicare Part D.
Background
Medicare beneficiaries without prescription drug coverage
have considerable difficulty filling prescriptions due to
costs. The Kaiser Family Foundation found that 26% of
seniors reported medication non-adherence due to cost,
including 35% of those with three or more chronic condi-
tions [1]. Medicare beneficiaries without drug coverage
filled one-third fewer prescriptions in 2002 than benefici-
aries with some form of drug coverage – a difference that
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persisted across a range of individual characteristics,
including health status and income [1].
On December 8, 2003, President George W. Bush signed
the Medicare Prescription Drug Improvement and Mod-
ernization Act of 2003 (the "MMA") into law, which
added a prescription drug benefit to the Medicare pro-
gram. The Medicare Prescription Drug Discount Card and
Transitional Assistance Program were intended as tempo-
rary measures to provide immediate assistance in lower-
ing prescription drug costs for persons in need. The law
made Medicare-approved Prescription Drug Discount
Cards available to Medicare beneficiaries as of May 2004,
in place until Medicare Part D prescription drug coverage
began on January 1, 2006 [2].
The net federal cost of Medicare Part D is estimated to be
$37 billion in 2006, increasing to $67 billion in 2010,
and totaling $724 billion for the decade of 2006–2015
[1]. Early reports suggested that the education of the pub-
lic lagged prior to implementation of Medicare Part D. A
survey conducted by the Kaiser Family Foundation August
4th through 8th, 2005, including 300 adults age 65 years or
older, found that only 33% of seniors felt that they had
enough information at that time about the new Medicare
prescription drug benefit to understand how it would
affect them personally, and only 22% of seniors
responded that they would enroll in a Medicare drug plan
when available. Of those who said that they would not
enroll or were not yet informed enough to make a deci-
sion, 26% felt that the system was too complicated. Only
about 7% had called the Medicare hotline and 6% stated
that a friend or family member had called the Medicare
hotline or visited the Medicare website on their behalf [3].
A USA Today/CNN/Gallup poll of 275 adults age 65 years
or older taken at the end of September 2005 reported that
37% of seniors stated that they understood the program at
least somewhat well, while 61% did not. Only 24% of
seniors surveyed stated that they planned to join Medicare
Part D, compared with 54% who did not plan to sign on
[4].
Persons with end-stage renal disease (ESRD) are among
those for whom per capita Medicare spending is highest –
$64,614 on average in 2003 [5] – and are disproportion-
ately poor. Moreover, ESRD patients typically use multi-
ple oral medications, including drugs for diabetes
mellitus, heart failure, hypertension, hyperphosphatemia
and other associated conditions. Patients with ESRD are
Medicare-eligible before the age of 65 years, and as a func-
tion of hemodialysis, are regularly in contact with physi-
cians, nurses, dietitians and social workers. Thus,
hemodialysis patients in particular should be informed of
this program and utilize it where appropriate.
Much can be learned about the potential long-term utili-
zation of Medicare Part D in the hemodialysis population
from examining the level of understanding and use of the
temporary Medicare Prescription Drug Discount Cards.
More than 7 million Medicare beneficiaries were eligible
for these cards, which were initially projected to offer dis-
counts of 10–25% [6]. A drug report from the Centers for
Medicare and Medicaid Services (CMS) released October
12, 2004, reported that beneficiaries could obtain dis-
counted prices 12–21% less than national average prices
paid by all Americans for commonly used brand name
drugs at retail pharmacies, with even larger discounts (28–
75%) on generic drugs [7]. Despite multiple projections
of potential cost savings, no studies to date have deter-
mined the actual benefit of the temporary Medicare Pre-
scription Drug Discount Cards accrued to individuals.
Information from such an inquiry would be valuable to
the ESRD patient and provider communities, as well as
more generally to the Medicare population.
To explore knowledge and utilization of Medicare Pre-
scription Drug Discount Cards, we surveyed a sample of
hemodialysis patients from two urban University-affili-
ated dialysis centers and a sample of dialysis care provid-
ers. We hypothesized that the levels of understanding and
use of these cards would be relatively low, despite a signif-
icant need.
Methods
We surveyed hemodialysis patients from two urban
hemodialysis centers affiliated with the University of Cal-
ifornia San Francisco (UCSF) during July and August
2005. Non-English-speaking individuals were not
approached. San Francisco General Hospital Dialysis Unit
largely serves a disenfranchised patient population with a
high proportion of minorities. The UCSF-Mt. Zion Dialy-
sis Unit serves an ethnically diverse, insured patient pop-
ulation. Patients were approached in person and asked to
complete the surveys while on hemodialysis. We asked for
information on current medical insurance coverage, pre-
scription drug coverage, ability to pay for medications and
the use of Medicare-approved Prescription Drug Discount
Cards. A total of 74 of 80 (93%) patients approached
returned completed surveys; four surveys were incomplete
and were not included. The most common reason for
nonparticipation was "feeling too tired" to complete the
survey during hemodialysis.
We also surveyed a group of University- and community-
based nephrologists preceding a UCSF Nephrology Grand
Rounds, and non-physician dialysis health care profes-
sionals at dialysis centers over the same time frame. A
total of 72 of 74 (97%) health care professionals returned
surveys, two of which were incomplete and not includedBMC Nephrology 2006, 7:11 http://www.biomedcentral.com/1471-2369/7/11
Page 3 of 5
(page number not for citation purposes)
in the analysis. The most common reason for nonpartici-
pation was "too busy."
Due to the small sample size and primarily descriptive
nature of the study, formal statistical testing was not pur-
sued. The study was approved by the UCSF Committee on
Human Research.
Results
Patient survey results are presented in Table 1. The major-
ity of participants were dually covered by Medicare and
Medi-Cal (California's Medicaid). Fifty-nine percent of
patients received prescription drug coverage through
Medi-Cal, 20% received benefits through another insur-
ance program, and 21% had no prescription drug cover-
age at all. Forty (57%) patients reported that they could
always obtain all of their medications. Of the 40, 20
(50%) received prescription drug coverage through Medi-
Cal and 12 (30%) through other insurance coverage. Forty
percent (6/15) of patients with no prescription drug cov-
erage reported that they were obtain their medications
"sometimes" or "rarely" vs. 22% (16/55) of patients with
some form of drug coverage. None of the patients sur-
veyed actually had a Medicare-approved prescription drug
card, and of those who intended to apply, only 3 (10%)
reported knowing how to do so.
The health professional survey results are presented in
Table 2. Only eight (11%) health care professionals knew
the eligibility requirements of the drug discount cards,
including only one of 17 (6%) nephrologists who care for
hemodialysis patients >20% of their clinical time. Only
five (7%) providers knew the eligibility requirements of
the low income subsidy, including none of the nephrolo-
gists. A small fraction of nephrologists were ever asked
about the Medicare prescription drug discount card by
patients, and even fewer could provide their patients with
relevant information (Table 2). Finally, of the ten provid-
ers that knew how to obtain a card, nine (90%) counseled
at least one patient to apply.
Table 1: Patient survey results
N = 70 (%)
SFGH 37 (53%)
Mt Zion 33 (47%)
"Do you have health insurance in addition to Medicare?"
Medical 43 (61%)
Insurance through employer 6 (9%)
Insurance through private plan 10 (14%)
No other insurance 11 (16%)
"Do you have prescription drug coverage?"
Medi-Cal 41 (59%)
Medicare-approved prescription discount card 0 (0%)
Through another drug benefit program 14 (20%)
No prescription drug coverage 15 (21%)
"Please mark the statement that best describes your current ability to obtain your prescription 
medications:"
I can always obtain all of my meds (100% of the time) 40 (57%)
I can usually obtain all of my meds (60–99%) 18 (26%)
I can sometimes obtain all of my meds (30–59%) 11 (16%)
I can rarely obtain all of my meds (<30%) 1 (1%)
"In the past 12 months, have you been unable to take a medication that was prescribed to you because 
you could not afford it?"
Yes 21 (30%)
No 49 (70%)
"Do you have a Medicare Prescription Drug Card?"
Yes 0 (0%)
No 70 (100%)
"Do you intend to apply for a Medicare Prescription Drug Card?"
Yes 31 (44%)
No 39 (56%)
"Do you know how to apply for a Medicare Prescription Drug Card?"
Yes 8 (11%)
No 62 (89%)
"Would you be interested in learning more about the Drug Cards?"
Yes 57 (81%)
No 13 (19%)BMC Nephrology 2006, 7:11 http://www.biomedcentral.com/1471-2369/7/11
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Discussion
Medicare Part D is an ambitious attempt to help Medicare
beneficiaries reduce out-of-pocket expenses for prescrip-
tion drugs. The average per capita drug spending among
Medicare beneficiaries in 2005 is estimated to be $2,864
[1]. Hemodialysis patients, by the nature of their disease,
often have extensive needs for prescription drugs. The
results described here support the observation that lack of
prescription drug coverage leads to difficulty in obtaining
necessary medications. The novel findings of this study
are 1) persons on hemodialysis had scarce knowledge
about the Medicare-approved Prescription Drug Discount
Cards, despite the need for multiple medications and sub-
optimal drug coverage; 2) discount cards were underuti-
lized in this group (zero of 70 patients); and 3) health care
professionals who care for a largely Medicare-eligible pop-
ulation demonstrated an egregious lack of knowledge
about this program.
Several caveats are worth noting. The patients surveyed
were from urban dialysis centers, and may not reflect the
knowledge base of the overall hemodialysis or home peri-
toneal dialysis populations. However, we selected Eng-
lish-speaking patients; we anticipate that non-English-
speaking patients may experience even more difficulty
navigating the system. It is possible that patients and pro-
viders in for-profit dialysis facilities may be better
informed, though many of the providers surveyed in this
study work jointly in independent and for-profit dialysis
facilities.
The educational and outreach efforts of CMS to date have
included information in 14 languages on the Medicare
website and through the 1-800-MEDICARE line, a bro-
chure for beneficiaries, a national multi-media campaign,
and a section in the Medicare & You 2005 handbook [8].
Despite the availability of these materials, and the exist-
ence of the Medicare Prescription Drug Discount Card
Table 2: Health care professionals survey results
N = 70 (%*)
Field of professionals-
Nephrologists with > 20% of time caring for HD patients** 16 (23%)
Nephrologists with < 20% of time caring for HD patients 11 (16%)
Nurse practitioner with > 20% of time caring for HD patients** 1 (1%)
Social worker 3 (4%)




"Do you know the eligibility requirements of the Medicare Prescription Drug Discount Cards?"
Yes 8 (11%)
No 62 (89%)
"Do you know the eligibility requirements of the low income subsidy?"
Yes 5 (7%)
No 65 (93%)
"Do you know which cards are available in your state/region?"
Yes 9 (13%)
No 61 (87%)
"Do you know how to get a card?"
Yes 10 (14%)
No 60 (86%)
"Have you ever counseled a patient to apply for a card?"
Yes 4 (6%)
No 66 (94%)
"Have you ever been asked by a patient which card you would recommend?"
Yes 4 (6%)
No 66 (94%)
"Have you ever been asked by a patient how to get a card?"
Yes 8 (11%)
No 62 (89%)
"Would you be interested in learning more about the Medicare Prescription Drug Discount Card?"
Yes 54 (77%)
No 16 (23%)
*May not equal 100 due to rounding error
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Program for over a year, hemodialysis patients and pro-
viders remained poorly educated about the Medicare Pre-
scription Drug Discount Cards. This has broad
implications for the dissemination of information about
Medicare Part D. While actions will speak louder than
words, the survey results suggest that providers would be
willing to assist patients in obtaining drug discount cards
once adequately informed.
The Kidney Medicare Drugs Awareness and Education Ini-
tiative was launched in Washington, D.C. on July 27,
2005 in an effort to inform patients with chronic kidney
disease about Medicare Part D. This initiative includes
more than 35 kidney organizations and companies, led by
the National Kidney Foundation (NKF). The centerpiece
of this initiative is a new website for patients and profes-
sionals [9]. The efforts of the CMS to bring information to
the general public about Medicare Part D include infor-
mation in the Medicare & You 2006 handbook, the new
"search tool" option on the Medicare website, the 1-800-
MEDICARE line [10], and an ad insert explaining the pro-
gram in the September 25, 2005, edition of Parade, a Sun-
day newspaper supplement with a circulation of 34.5
million people. In addition, the American Association of
Retired Persons (AARP), the nation's largest advocacy
group for seniors, has sponsored education campaigns.
Conclusion
Of the 43.1 million current Medicare beneficiaries, 29.3
million (70%) are expected to enroll in Medicare Prescrip-
tion drug plans over the course of this year according to
the Administration [1]. Members of the dialysis provider
communities must be better educated, so that dialysis
patients have the information and tools to take advantage
of these programs.
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